Aprogen, Inc
Aprogen operates pharmaceutical and biopharmaceutical divisions producing synthetic drugs and antibody biosimilars alongside metal and insulation businesses.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1971, Aprogen listed on the KOSPI in 1995 as a diversified company spanning metals, pharmaceuticals, insulation, and biopharmaceuticals. Its pharmaceutical division (50.35% of sales) sells synthetic drugs such as the circulatory drug Rozettam Tablet and the digestive drug Easylong Oral Solution along with cosmetics, while its biopharmaceutical division develops four antibody biosimilars—for Herceptin, Humira, Rituxan, and Remicade—and a dual-receptor new drug for degenerative arthritis. It also runs Korea's No.1 metal hardfacing business (28.59% of sales) and the NUKON insulation system for nuclear power plants (2.05% of sales), posting total sales of KRW 117,974 million in its 55th fiscal year.
Products & technology
- 로젯탐정
- 엑사디핀정
- 글리콜린연질캡슐
- 토프라맥정
- 이지롱내복액
- 레바미피드정
- 가베스판연질캡슐
- 리버킹연질캡슐
- 네오히알주
- 히알로지 피이펙트 리라이언스 젤
- 허셉틴 바이오시밀러
- 휴미라 바이오시밀러
- 리툭산 바이오시밀러
- 레미케이드 바이오시밀러
Clinical trials
data.go.kr1 MFDS clinical trial authorisations · 2026 (Phase 1 1)
- Phase 1AP2092026-06-09
4 trial sites
R&D and key agreements
Source: DART corporate disclosure퇴행성 관절염 치료용 이중 수용체 신약 · 퇴행성 관절염 · 연구개발 · Biopharmaceutical pipeline candidate (source text truncated after this point)
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition